HOUSTON, March 15, 2016 -- VAALCO Energy, Inc. (NYSE:EGY) today announced that it has rescheduled its fourth quarter 2015 earnings release to be after the close of trading on Wednesday, March 16 and will host a conference call to discuss fourth quarter and year end 2015 results on Thursday morning March 17 at 9:00 a.m. Central Time (10:00 a.m. Eastern Time.)
Please note the new call-in numbers and confirmation code below.
Interested parties may participate by dialing (800) 230-1096. International parties may dial (612) 288-0340. The confirmation code is 389345. This call will also be webcast on VAALCO's website at www.vaalco.com.
An audio replay will be available beginning approximately one hour after the end of the conference call through April 17, 2016, on the Company's website and by dialing (800) 475-6701. International parties may dial (320) 365-3844. The confirmation code is 389345.
About VAALCO
VAALCO Energy, Inc. is a Houston-based independent energy company principally engaged in the acquisition, exploration, development and production of crude oil. The Company's properties and exploration acreage are located primarily in Gabon, Equatorial Guinea and Angola in West Africa.
Investor Contacts Don McCormack Chief Financial Officer 713-212-1038 Al Petrie Investor Relations Coordinator 713-543-3422


Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



